TY - JOUR A1 - Deltz, E. A1 - Müller-Hermelink, HK A1 - Ulrichs, Karin A1 - Thiede, A. A1 - Müller-Ruchholtz, W. T1 - Development of graft-versus-host reaction in various target organs after small intestine transplantation N2 - The GVHRIL foHowing transplantation of small intestine are different from those found after bone marrow transplantation or spleen cell injections in that they show a remarka ble, significant prevalence of lesions within the intestinal mucosa. These findings are consistent with the observation that jntestinal lymphocytes newly formed in mesenteric lymph nodes predominantly home in on the intestine again.& The degree of histologic alteration within different tissues indicates that the graft and the host may survive the lesions of the lymphatic tissues, whereas the severe intestinal lesions following GVHR may easily cause death of the recipient. With regard to clinical sman bowel transplantation two statements can be made: (l) GVHRIL play a significant role in small bowel trans~ plantation. (2) To minimize their biologic importance, a selective elimination of the graft's Jymph nodes by irradiation or surgical resection should be considered in view of the remarkable difference between GVHRIL in lymph nodes and in the graft's intestinal wall itself. KW - Chirurgie Y1 - 1981 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45459 ER - TY - JOUR A1 - Waaga, AM A1 - Krzymanski, M. A1 - Ulrichs, Karin A1 - Wierusz-Wysocka, Bogna A1 - Müller-Buchholtz, Wolfgang T1 - Hematological effects of the new immunosuppressive drug 15-deoxyspergualin N2 - Since systematic hematological studies on blood and bone marrow changes after treatment with 15-Deoxyspergualin (DOS) are lacking, a quantitative assessment was performed fourteen or twenty eight days after intraperitoneal application of DOS to rats. Further observations done 7 and 14 days after discontinuation of DOS administration allowed analysis of banc marrow regeneration. DOS induced lymphocytopenia, granUlocytopenia and anemia with a decrease of bone marrow cellularity due to suppression of cell maturation. The effect was dose-dependent and bone marrow as well as blood changes were observed in animals treated with doses from 0.5 to 10.0 mg/kg DOS. Within 14 days after termination of the treatment, rapid recovery with normalization of all hematological parameters was observed. In the light of our data, these hematological side effects may not be a major disadvantage, if DOS is used in doses below 2.5 mg/kg, and for a course of therapy which is limited to 7 to 14 days. KW - Chirurgie KW - 15-Deoxyspergualin KW - hematology KW - immunosuppression KW - bone marrow KW - regeneration KW - experimental therapy Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-44701 ER - TY - JOUR A1 - Heiser, Axel A1 - Ulrichs, Karin A1 - Müller-Buchholtz, Wolfgang T1 - Isolation of porcine pancreatic islets: low trypsin activity during the isolation procedure guarantees reproducible high islet yields N2 - During the past few years, interest in xenotransplantation of porcine islets of Langerhans for the future therapy of type I diabetes has Increased markedly. Therefore, we established a semiautomated digestion method for isolating islets from the porcine pancreas. However, although the isolation technique was standardized and collagenase of controlled quality was used, we were unable to attain high islet yields with a satisfactory degree of reproducibility. One hypothesis was that varying degrees of interference by donor pancreatic enzymes were responsible for this failure. The aim of this stUdy was to examine the kinetics of four types of enzymatic activity during the isolation procedure, as well as their effects on islet yield: collagenase, trypsin, neutral protease, and clostripaln. Our results indicate that while exogenous collagenase activity decreases slightly during the isolation procedure, the activity of the pancreas enzymes neutral protease and trypsin increases. In some cases, trypsin activity increases very strongly. A strong increase in trypsin activity correlates with poor islet yield, whereas low trypsin activity always correlates with high islet yield. Addition of the protease inhibitor Pefabloc to the isolation medium results in low trypsin activity and reproducible high islet yields. KW - Langerhans-Inseln KW - islets of Langerhans KW - xenogeneic transplantation KW - swine KW - enzyme activation KW - enzyme inhibitors Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-44719 ER - TY - JOUR A1 - Winoto-Morbach, S. A1 - Ulrichs, Karin A1 - Hering, BJ A1 - Leyhausen, G. A1 - Müller-Ruchholtz, W. T1 - Lectins for electromagnetic purification of islets from humans and large mammals N2 - No abstract available KW - Chirurgie Y1 - 1990 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45430 ER - TY - JOUR A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, W. T1 - Mixed lymphocyte islet culture (MLIC) and its use in manipulation of human islet alloimmunogenicity N2 - No abstract available Y1 - 1990 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45515 ER - TY - JOUR A1 - Ulrichs, Karin A1 - Kuhlencordt, KM A1 - Müller-Ruchholtz, W. T1 - Plating inhibition assay (PIA): a new test for cell mediated cytotoxicity N2 - No abstract available Y1 - 1979 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45443 ER - TY - JOUR A1 - Ulrichs, Karin A1 - Deltz, E. A1 - Thiede, A. A1 - Müller-Ruchholtz, W. T1 - Lymphoid tissue transplantation in rats leads to a GVHR, inducing a specific T-cell mediated autoreactivity against MHC-antigens N2 - No abstract available Y1 - 1982 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45420 ER - TY - JOUR A1 - Ulrichs, Karin A1 - Müller-Buchholtz, W. T1 - MHC class II antigen expression on the various cells of normal and activated isolated pancreatic islets N2 - It is the aim of this study to characterize and quantify the cells within isolated rat islets that express MHC class 11 antigens. A set of five monoelonal antibodies and two polyclonal antisera of defined specificlty were used in combination with a newly devised procedure for three·dimensional immunofluorescence evaluation of intact islets. It is shown that in addition to passen· ger cells, such as Iymphocytes, macro· phages, and dendrlticlike cells, vascular endothelial and endocrine cells are also capable of expressing class 11 antigens. This expression Is strongly influenced by in vitro culture. pregnancy, streptozotocin- induced diabetes, transplantation trauma, and alloantigenic stimuli. The pos· sible role of the above cells in antigen presentation related to islet transplantation is discussed. KW - pancreas Islets KW - beta cells KW - islet transplantation KW - la antigens Y1 - 1985 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-44722 ER - TY - JOUR A1 - Ulrichs, Karin A1 - Schang, T. A1 - Keller, R. A1 - Müller-Ruchholtz, W. T1 - Reactivity of pancreas islet cells with antisera of known specificity N2 - No abstract available Y1 - 1984 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45466 ER - TY - JOUR A1 - Heiser, A. A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, W. T1 - Prophylactic trypsin inhibition during the isolation procedure guarantees reproducible, high porcine islet yields N2 - Abstract: For isolating islets from the porcine pancreas, we established a semiautomated digestion method. Although the isolation technique was standardized and collagenase of controlled quality was used, until now the reproducibility of high islet yields was unsatisfactory. Our hypothesis was that pancreatic trypsin was responsible for this failure. The aim of this study was to investigate the effect of endogenous trypsin on islet yield. Our results demonstrate that a high trypsin level correlates with poor islet yield, whereas low trypsin activity always correlates with high islet yield. Specific inhibition of trypsin results in low trypsin activity and reproducible, high islet yields. KW - islets of Langerhans KW - xenogenic transplantation KW - swine KW - enzyme activation KW - enzyme inhibitors Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45531 ER - TY - JOUR A1 - Engemann, R. A1 - Ulrichs, Karin A1 - Thiede, A. A1 - Müller-Ruchholtz, W. A1 - Hamelmann, H. T1 - Value of a physiological liver transplant model in rats. Induction of specific graft tolerance in a fully allogeneic strain combination N2 - No abstract available Y1 - 1990 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45622 ER - TY - JOUR A1 - Ulrichs, Karin A1 - Yu, MY A1 - Duncker, D. A1 - Müller-Ruchholtz, W. T1 - Immunosuppression by cytostatic drugs? N2 - In the present study, an attempt was made to characterize the immunomodulating abilities of the cytostatic drugs cydophosphamide, ifosfamide, vinblastine, vincristine, procarbazine, dacarbazine, 6-mercaptopurine, methotrexate, 5-f/uor-uracil and adriamycine in a defined experimental model. Varying combinations of drug plus transplantation alloantigen, (C3H-lymphocytes) were injected into Balb/c mice at different time intervals in vivo. The resulting T-effector cell reactivity was determined in vitro with the microcytotoxicity assay on day + 5 for primary (r) and day + 7 for secondary (2°) sensitized mice. According to the type of drug (alkylating agent vs. vinca alkaloid vs. antimetabolite vs. cytostatic antibiotic), the dosage (20% LD50 vs. 60% LD50), the state of sensitization (r vs. 2° sensitized recipients), and the time of drug application in relation to the antigen treatment on day 0 (in varying steps from day -6 to day +4), so-called "pharmaconantigen- variation-effects" (PA VE) were established for each of the investigated drugs in form of reaction profiles. The results were as folIows: (1) For almost alt substances, characteristic reaction profiles involving immunostimulation and/or immunosuppression could be established. Similarities in the profiles of different substances made it possible to classify the drugs according to different reaction types. The reaction type however is not definitely correlated to the biochemical mechanism of drug action. (2) The PA VE are decisively inf/uenced by so me of the biological parameters, such as the time of drug application in relation to the antigen treatment and the state of sensitization but relatively !ittle by the dosage of the drug. (3) Considering the different processes occurring du ring primary and secondary immune responses, the PAVE may give hints for a distinct manipulation of the immunoregulation and thus information on the immunobiological mechanism of drug action. KW - Immunologie Y1 - 1984 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45574 ER - TY - CHAP A1 - Kaitschick, J. A1 - Ulrichs, K. A1 - Müller-Ruchholtz, W. T1 - The New Immunosuppressant Leflunomide Appears To Be a Potent Inhibitor of Humoral Xeno Sensitization N2 - No abstract available KW - Immunbiologie Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45727 ER - TY - CHAP A1 - Winoto-Morbach, S. A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, W. T1 - New Developments in Biodegradable Microspheres For Magnetic Separation Techniques N2 - No abstract available KW - Immunbiologie Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45712 ER - TY - CHAP A1 - Eckstein, V. A1 - Ulrichs, Karin A1 - Meincke, G. A1 - Mülller-Ruchholtz, W. T1 - Transplantation of Diabetic Patients With Xenogeneic Pancreatic Islets Has to Consider Natural Xenophile Antibodies (NXA) In Patients Sera As a Major Obstacle to Success N2 - No abstract available KW - Immunbiologie Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45707 ER - TY - GEN A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, W. T1 - Identification and Manipulation of Human Islet Alloimmunogenicity: Morphologic and Functional in Vitro Studies with Various Islet Preparations N2 - No abstract available KW - Immunbiologie Y1 - 1989 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45584 ER - TY - CHAP A1 - Heiser, A. A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, W. T1 - Enzyme Activities in Commercial Collagenase Preparations and Their Kinetics During Islet Isolation Procedure N2 - No abstract available KW - Transplantation Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45633 ER - TY - CHAP A1 - Wang, HY A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, W. T1 - Down-Regulation of Xenophile Antibodies by Specific Immunosuppressive Protocols to Facilitate Xenogeneic Organ Transplantation N2 - No abstract available KW - Immunbiologie Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45669 ER - TY - CHAP A1 - Ulrichs, Karin A1 - Eckstein, V. A1 - Korsgren, O. A1 - Müller-Ruchholtz, W. T1 - Expression of Porcine Pancreatic Islet Antigens Varies and Determines Binding of Human Natural Xenophile Antibodies (NXA) N2 - No abstract available KW - Immunbiologie Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45655 ER - TY - CHAP A1 - Hedke, K. A1 - Eckstein, V. A1 - May, G. A1 - Kaden, J. A1 - Müller-Ruchholtz, W. A1 - Ulrichs, Karin T1 - Production of Xenophile Antibodies (XA) in Type I Diabetic Patients is Strongly Influenced by Diabetes and/or Dialysis N2 - No abstract available Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45642 ER - TY - CHAP A1 - Heiser, A. A1 - Ulrichs, Karin A1 - Eckstein, V. A1 - Müller-Ruchholtz, W. T1 - The Human Cell Mediated Response to Xenogeneic (Porcine) Transplantation Antigen Depends on the Stimulator Cell Compartment N2 - No abstract available Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45670 ER - TY - CHAP A1 - Ulrichs, Karin A1 - Euler, HH A1 - Müller-Ruchholtz, W. T1 - A Clinically Successful Protocol to Suppress Autoantibody Production in SLE Patients Is Analyzed For Its Efficacy To Inhibit Natural Xenophile Antibodies (NXA) N2 - No abstract available Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45693 ER - TY - JOUR A1 - Winoto-Morbach, Supandi A1 - Ulrichs, Karin A1 - Leyhausen, Gaby A1 - Müller-Ruchholtz, Wolfgang T1 - New principle for large-scale preparation of purified human pancreas islets N2 - Because successful human islet transplantation requires large quantities of viable islets that must be separated from the highly immunogenic exocrine tissue and because handpicking is too time-consuming and laborious to be clinically relevant, a new approach for solving this problem has been established in rat models. It is based on the principle that magnetic microspheres (MMSs) coupled to lectins with binding specificity for the exocrine tissue portion are trapped in an electromagnetic field, thus providing effluent islets of a high degree of purity. In this study our aim was to adapt this princip'le to human islet preparations. In this context our prime interest was focused on a lectin suitable for human pancreatic tissue. Of 19 different lectins tested, only 1, Wisteria floribunda agglutinin (WFA), is suitable, as shown by immunofluorescence, MMS-Iectin binding, and magnetic separation KW - Immunbiologie Y1 - 1989 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45600 ER - TY - JOUR A1 - Von Gaudecker, Brita A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, Wolfgang T1 - Immunoelectron microscopic localization of MHC structures in isolated pancreatic rat islets N2 - An immunogold-silver enhancement technique, which combines effective labeling of viable isolated islets with the ultrastructural resolution of cytological details, was applied in electron microscopy to identify major histocompatibility complex (MHC) structures on islet cells. Incubation of freshly isolated islets from CAP (RT1C) and LEW (RT1') rats with OX18, an MHC class I antibody, showed strong positive reactivity in macrophages and/or dendritic-like cells (M0-DCs) and vascular endothelial cells (VEs) and a comparatively weaker reactivity in endocrine a-, p-, and 8-ce"s. With MHC class" antibody OX6 (anti-I-A), M0-DCs were strongly labeled in both rat strains on the surface and on internal structures. Three of five particularly high titered batches of OX6 revealed MHC class" expression on VE and p-ce"s. Four days of in vitro culture in combination with a high concentration of glucose and interferon-'Y induced strong enhancement of MHC class I structures and, to a lesser extent, class " structures on p-ce"s. KW - Immunbiologie Y1 - 1989 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45596 ER - TY - JOUR A1 - Kekow, Jörn A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, Wolfgang A1 - Gross, Wolfgang L. T1 - Measurement of rat insulin. Enzyme-linked immunosorbent assay with increased sensitivity, high accuracy, and greater practicability than established radioimmunoassay N2 - Total immunoreactive insulin (IRI) is conventionally determined by radioimmunoassays. IR! measurement in rats can be made more sensitive, accurate, and practical, as demonstrated by a new modified enzyme-linked immunosorbent assay (ELlSA). It is characterized by indirect binding of an anti-insulin antibody by an antiglobulin antibody and uses the principle of competitive saturation. In this ELlSA, IRI can be determined in a wide range of concentrations, corresponding to the standards. The standard curve ranges from 100 to 0.049 ng/mllRI (1 ng/ml - 23.4 JLU/ml - 172 pM rat insulin). The statistical analysis shows between- and within-assay coefficients of variation of :515%. Diabetes 37:321-26,1988 KW - Chirurgie Y1 - 1988 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45543 ER - TY - CHAP A1 - Heiser, A. A1 - Ulrichs, Karin A1 - Eckstein, V. A1 - Müller-Ruchholtz, W. T1 - Xenogeneic Cellular Response of Human Lymphocytes Against Porcine Lymphocytes and Isolated Pancreatic Islets N2 - no abstract available Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45479 ER - TY - CHAP A1 - Heiser, A. A1 - Ulrichs, Karin A1 - Müller-Ruchholtz, W. T1 - Enzyme Kinetics of Commercial Collagenases and their Influence on Porcine Islet Isolation N2 - No abstract available KW - Heterotransplantation Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-45488 ER - TY - THES A1 - Tiurbe, George Christian T1 - Characterization of immature rat bone marrow-derived dendritic cells : Evaluation of their phenotype and immunomodulatory properties in vitro and after organ transplantation T1 - Charakterisierung unreifer dendritischer Zellen aus dem Knochenmark der Ratte: Untersuchungen zum Phänotyp und zur Immunmodulation in vitro und nach Organtransplantation N2 - Solid organ transplantation is an established therapeutic approach in modern medicine to extend and to improve the life of patients in the final stages of organ failure. Transplantation between genetically non-identical individuals leads to the activation of the transplant recipient's immune system. This alloimmune response is a consequence of the recognition of foreign MHC molecules by alloreactive host T cells. To prevent their activation and the subsequently induced activation of further cell subsets (e.g. B cells, cytotoxic T cells, macrophages)immunosuppressive drugs are absolutely necessary in the clinic. However,permanent immunosuppression leads to severe side effects such as nephrotoxicity, diabetes and hyperlipidaemia, and a reduced immunity to infections and malignant diseases. At the moment, there is no real alternative to immunosuppression. The purpose of this study was to analyse the importance of rat dendritic cells with immune inhibitory properties to prevent the immune activation after experimental transplantation. The rat is one of the most important animal models for experimental organ transplantation in a clinic-relevant procedure. In order to modulate the immune response after transplantation in an antigenspecific manner, the strategy should include the alloantigens. These antigens have to be presented by immature dendritic cells in the absence of costimulatory signals in order to turn alloreactive T cells into anergic or regulatory T cells instead of effector T cells. For a certain rat model of allograft rejection,the immunodominant peptide P1 was identified as an important alloantigen which accelerates graft rejection. Such a model offers an attractive and practical approach to analyse the potential of host tolerogeneic dendritic cells pulsed with P1 to suppress the allograft-induced immune response in an antigen-specific manner without the need of chronic immunosuppression. A homogenous population of rat immature dendritic cells was generated from bone marrow precursors cultured with GM-CSF and IL-4 (= IL-4 DCs) or GM65 CSF and IL-10 (= IL-10 DCs). These cells with an identical immature phenotype showed no or a very low surface expression of costimulatory molecules like CD80 and CD86 and a 10-fold reduced expression of MHC class II molecules in comparison to mature splenic DCs. No obvious difference was observed between the phenotype of the IL-4 DCs and the IL-10 DCs. Neither IL-4 DCs nor IL-10 DCs were able to activate naïve T cells or to restimulate antigen-specific T cells. This strong inhibitory effect, mediated within 24 hours, was dependent on the number of immature dendritic cells added to the proliferation assay. Antigen-specific T cells pre-incubated with IL-4 DCs and IL-10 DCs, respectively, were not able to proliferate in the presence of P1-pulsed mature DCs. This anergic state was reversible with the addition of exogenous IL-2. T cells incubated with IL-4 DCs (= IL-4 DC-Ts) were able to inhibit the T cell proliferation in a cell number dependent manner. In contrast, antigen-specific T cells pre-incubated with P1-pulsed IL-10 DCs (= IL-10 DC-Ts)showed no effect on the proliferation assay. This was the unique difference between IL-4 DCs and IL-10 DCs found in the present study. Immature DCs influenced also the immune response after transplantation. Different numbers of P1-loaded immature IL-4 DCs and IL-10 DCs were transferred intravenously into Lewis rats one day before transplantation. The best results were obtained with 30 million P1-pulsed immature DCs which prolonged the survival time to a median of 11.2 ± 1.6 days. In addition, the antigen specificity of this effect was demonstrated with a third-party graft from Brown Norway donors. These findings suggest that an antigen-specific modulation of the immune response is possible using immature dendritic cells loaded with the allogeneic antigens. Even more, the protocols described in the present study show that the immune system can be, at least temporarily, controlled after transplantation without the use of immunosuppressive drugs. N2 - Die allogene Organtransplantation, d.h. die Übertragung zwischen genetisch nicht-identischen Individuen der gleichen Spezies, ist bei irreversiblen Organerkrankungen nach wie vor die Therapie der Wahl. Die Transplantatabstoßung ist eine zum Funktionsverlust von Organtransplantaten führende T-Zellvermittelte Immunantwort. Ihre Ursache liegt in der Inkompatibilität von Organtransplantat und Transplantat-Empfänger hinsichtlich der Moleküle des Haupthistokompatibilitätskomplexes,die auch als Alloantigene bezeichnet werden. Zwar lässt sich die Transplantatabstoßung mit immunsuppressiven Medikamenten hemmen, doch vermindern diese die Immunabwehr und begünstigen die Entstehung von Infektionen und Tumorerkrankungen. Für die klinische Transplantation gibt es momentan keine Alternativen zur Immunsuppression. Um das Transplantat ohne Immunsuppression dauerhaft zu schützen, müssen die regulatorischen Komponenten des Immunsystems gezielt gestärkt werden. Das Ziel dieser Arbeit war es deshalb, die inhibierende Wirksamkeit unreifer dendritischer Zellen auf die nach Transplantation einsetzende Alloimmunantwort zu überprüfen. Charakteristisch für die Alloimmunantwort ist die Vielzahl der beteiligten Alloantigene. Doch ist es in den letzten Jahren gelungen, Peptidantigene mit einer nachweisbaren Funktion bei der Transplantatabstoßung (vermittelt über den indirekten Weg der Alloantigenerkennung) zu identifizieren. Für die in dieser Arbeit verwendete experimentelle Spender-Empfänger-Kombination ist die Bedeutung des Alloantigens P1, hierbei handelt es sich um ein aus 19 Aminosäuren bestehendes Peptid, für die Alloimmunantwort bekannt. Autologe unreife dendritische Zellen lassen sich aus Knochenmarkvorläuferzellen mit GM-CSF und IL-4 (diese Zellen werden als IL-4 DCs bezeichnet) bzw. mit GM-CSF und IL-10 (IL-10 DCs) kultivieren. Sowohl für IL-4 DCs als auch IL-10 DCs wurde keine bzw. eine sehr geringe Expression der kostimula67 torischen Moleküle CD80 und CD86 auf ihrer Zelloberfläche nachgewiesen. Die Oberflächenexpression von MHC-Klasse II Molekülen war im Vergleich zu reifen, aus der Milz isolierten dendritischen Zellen, um den Faktor 10 reduziert. In einem nächsten Schritt wurde die Wirkung von IL-4 DCs und IL-10 DCs auf T-Lymphozyten getestet. Sie können weder naive T-Lymphozyten aktivieren noch antigenspezifische T-Lymphozyten restimulieren. Der von diesen Zellen vermittelte suppressive Effekt wurde innerhalb von 24 Stunden wirksam und war eindeutig abhängig von der Zellzahl. Antigenspezifische T-Lymphozyten waren nach ihrer Inkubation mit IL-4 DCs oder IL-10 DCs nicht mehr mit P1- beladenen reifen DCs zu restimulieren. Dieser anergische Zustand ließ sich aber nach Zugabe von IL-2 aufheben. Anergische T-Lymphozyten, die mit IL-4 DCs kokultiviert wurden (= IL-4 DC-Ts), zeigten ihrerseits einen inhibierenden Effekt auf antigenspezifische T-Lymphozyten. Im Gegensatz dazu waren IL-10 DC-Ts hierzu nicht in der Lage. Dies ist der einzige Unterschied zwischen IL-4 DCs und IL-10 DCs, der in dieser Arbeit gefunden wurde. Auch in vivo zeigten IL-4 DCs und IL-10 DCs sowohl eine inhibierende Wirkung auf die lokale T-Zellpopulation als auch einen protektiven Effekt auf die Transplantatfunktion. Diese ließ sich in Abhängigkeit von der Zellzahl um 4 Tage ohne jegliche Unterstützung mit Immunsuppressiva verlängern. Dabei wurden maximal 30 Millionen unreife DCs pro Lewis Ratte eingesetzt, was ca. 10 Millionen Zellen pro 100 g Körpergewicht entspricht. Ihr immunprotektiver Effekt war dabei eindeutig antigenspezifisch. Insgesamt lassen die Ergebnisse den Schluss zu, dass autologe unreife dendritische Zellen, beladen mit Alloantigenen, eine hochattraktive Strategie zur antigenspezifischen Modulation der Alloimmunantwort nach Transplantation darstellen. In weiteren Studien soll die Effizienz dieser Zellen gesteigert werden. KW - dendritische Zellen KW - Organtransplantation KW - dendritic cells KW - Organtransplantation Y1 - 2006 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-21429 ER - TY - THES A1 - Sitaru, Ana Gabriela T1 - Modulation of the T cell response with MHC class I peptides and their analogues T1 - Modulation der T-Zell-Reaktivität durch MHC-Klasse-I Peptide und ihre Varianten : Perspektiven für eine antigen-spezifische Therapie in der Transplantation N2 - Transplantation is now firmly established as a therapeutic approach to extend and improve the life of patients in the final stages of organ failure. It has been demonstrated that transplantation between genetically non-identical individuals leads to the activation of the recipient’s alloimmune response as a major determinant of transplant outcome. T cell recognition of foreign MHC molecules plays a key role in initiating and sustaining allograft rejection. To prevent the risk of rejection, patients are given immunosuppressive drugs, which are non-specific and have major side-effects (infections, malignancies). It has been shown that the alloreactive T cells specifically recognize donor MHC-derived peptides. This implies that it may be possible to develop antigen-specific strategies in order to modulate the alloimmune response by peptide analogues and specifically altered peptide ligands. The purpose of this study was to explore the potential of “recipient-adapted” analogues from the dominant MHC class I peptide to modulate the alloimmune response. Beside the significant role of donor dominant determinants in the rejection process, we tested seven 13-to-24-mer peptides from the Wistar-Furth MHC class I molecule (WF, RT1.Au) for their possible immunogenicity in a fully MHC-mismatched WF to Lewis (LEW, RT1l) rat strain combination. Secondly, the immunodominant allopeptide was selected to generate analogues in order to investigate their modulatory capacity. All peptides were tested in vitro in a standard proliferation assay and in vivo using a heterotopic heart transplantation model. Our findings show that five peptides (P1-P5) were able to induce specific T cell proliferation in LEW responders. Furthermore, we found a hierarchical distribution of the determinants: peptide P1 as a good candidate for the immunodominant determinant, while P2, P3, P4, and P5 as subdominant epitopes and the other two peptides, P6 and P7, as non-immunogenic determinants of WF MHC class I molecule. Furthermore, the dominance of P1 was confirmed by the strong proliferation induced after immunization with a mixture of peptides in the presence of P1. This hierarchical distribution of the proliferative response correlated with the cytokine production. Peptide P1, comprising only 3 allogeneic amino acids (L5, L9, and T10) induced the strongest T cell proliferation and produced high levels of cytokines, especially IL-2 and IFN-g. In addition, the immunodominance of peptide P1 was confirmed by the significant reduction in the allograft survival time in comparison to the non-immunized control animals. Since the TCR Vß repertoire of rejected graft-infiltrating cells in rejected allografts was similar to the profile observed after in vitro restimulation of P1-primed T cells, we concluded that peptide P1 is able to activate the alloreactive T cell population. Our results demonstrate the particular role of the dominant peptide P1 (residues 1-19) in the allograft rejection in WF to LEW rat strain combination. In the second set of experiments, we investigated the fine specificity of the dominant peptide P1-activated T cells using peptide analogues from P1. The “recipient-adapted” analogues were designed by changing the allogeneic RT1.Au amino acids (L5, L9, T10) one-by-one with the correspondent syngeneic RT1.Al amino acids (M5, D9, I10) in the sequence of peptide P1. The six peptide analogues (A1.1-A1.6) consisting of either one or two allogeneic amino acids were able to induce a specific T cell proliferative response and cytokine production. Analogue A1.5 with only one allogeneic amino acid (L5) was of particular interest because it induced a low T cell proliferation and high cytokine levels, especially IL-4 and IL-10. In addition, immunization with A1.5 did not influence the allograft survival time in comparison to the non-immunized LEW recipients. A1.5 was the only analogue able to down-regulate the proliferation of P1-primed T cells. Our results reveal that A1.5 is an MHC competitor as confirmed by the in vitro MHC competition assay and the inhibition of the negative effect of P1 on the allograft survival time when recipients were immunized with a mixture of P1 and A1.5. These findings suggest that it is possible to design peptide analogues, such as A1.5, which do not stimulate the dominant peptide P1-specific T cell population and even more, are able to block its presentation in the MHC molecule. In all, the results indicate that the specific suppression of indirect allorecognition can be achieved by using peptide analogues of the dominant allopeptide. N2 - Ursache der Transplantatabstoßung ist in erster Linie die genetische Differenz im Haupthistokompatibilitätskomplex (MHC) zwischen Transplantatspender und Empfänger. Dabei stellen die aus den Fremd-MHC-Molekülen durch empfänger-eigene antigenpräsentierende Zellen prozessierten MHC-Peptide einen wichtigen Stimulus zur Aktivierung alloreaktiver T-Lymphozyten des Transplantat empfängers dar. Für die Transplantation bedeutsam ist, dass sowohl diese, als auch synthetische MHC-Peptide, wenn sie die genetische Differenz zwischen einer bestimmten Spender-Empfänger-Kombination repräsentieren, die Alloimmunantwort induzieren und damit die Abstoßung fördern. Das Ziel dieser Arbeit war, dass bereits in zahlreichen Experimentalmodellen für Autoimmunerkrankungen erfolgreiche Konzept der antigenspezifischen Immuntherapie mit Peptidvarianten oder altered peptide ligands auf die Transplantation zu übertragen. Anders als bei Autoimmunerkrankungen basiert die Alloimmunantwort aber nicht auf ein einyelnes Peptidantigen und darüber hinaus beeinflußt die jeweilige Spender-Empfänger-Kombination sehr stark dieses Peptidantigen-Repertoire. Um die Frage zu klären, welche der potentiellen MHC-Peptidantigene in der Alloimmunaktivierung dominieren, wurden Untersuchungen im Nagermodell für die allogene Spender-Empfänger-Kombination Wistar-Furth (WF, RT1u) und Lewis (LEW, RT1l) durchgeführt. Für die Transplantation wird erwartet, dass solche gezielt hergestellten Peptidvarianten sowohl die Aktivierung alloreaktiver T-Lymphozyten als auch weitere Funktionen, wie z. B. die Produktion von Cytokinen, hemmen. Dieser antigenspezifische, und wahrscheinlich auch nebenwirkungsfreie Therapieansatz könnte möglicherweise zur langfristigen Erhaltung der Transplantatfunktion führen. Durch Vergleich der Sequenzen für das MHC-Klasse-I Molekül beider Ratten-Stämme wurden für die a1 und a2 Domäne - dies ist der extrazelluläre, für die Bindung von Peptiden unterschiedlichster Herkunft verantwortliche Bereich des Moleküls - insgesamt 34 Positionen identifiziert, in denen beide Stämme unterschiedliche Aminosäuren aufweisen. Diese Differenzen werden von sieben synthetischen, mit den entsprechenden Bereichen des Spender MHC-Klasse-I Moleküls identischen MHC-Peptiden repräsentiert, welche zwischen 13 und 24 Aminosäuren lang sind. Die immunstimulierende Wirkung dieser Peptide (P1 bis P7) wurde im Proliferationsassay und im Transplantationsmodell bestimmt. Ausschließlich das Peptid mit der Bezeichnung P1 induzierte mit über 20.000 cpm die stärkste, mit einen Th1-dominierten Cytokinmuster (IL-2 und IFN-g) einhergehende T-Zellproliferation. Lewis-Empfänger, die vor der Transplantation mit diesem Peptid immunisiert wurden, stießen ihre von WF-Spendern stammenden heterotopen Herztransplantate beschleunigt ab. Von sieben potentiellen Peptidantigenen induzierte somit ausschließlich Peptid P1 eine dominante Alloimmunaktivierung und erscheint als Peptidantigen zur Herstellung von Peptidvarianten prädestiniert. P1 weicht in drei Aminosäurepositionen von der entsprechenden Sequenz der Lewis-Ratte ab. Durch sequentiellen Austausch dieser drei in der WF-Sequenz befindlichen allogenen Aminosäuren durch die entsprechenden syngenen Aminosäuren in der LEW-Sequenz führte zu sechs Peptidvarianten. Diese Empfänger-angepassten Varianten A1.1 bis A1.6 wurden anschließend auf ihre Fähigkeit untersucht, eine peptidspezifische T-Zellproliferation zu inhibieren, die möglicherweise mit einer protektiven Wirkung auf die Transplantatfunktion einhergeht. Von diesen Peptidvarianten induzierte nur Variante A1.5, sie besitzt noch eine allogene Aminosäure an Position 5, eine reduzierte T-Zellproliferation von 11.450 cpm, die mit einem Th2-dominierten Cytokinmuster (IL-4 und IL-10) korreliert. Zusätzlich hemmte A1.5 die Proliferation der P1-spezifischen T-Lymphozyten. Im Gegensatz zum Ausgangs-peptid P1 beeinflußte A1.5 nicht die Abstoßung heterotoper Herztransplantate und konnte, wurde es in Kombination mit P1 appliziert, die P1-induzierte Transplantatabstoßung verzögern. Um diese immunmodulatorische Fähigkeit der Variante A1.5 weiter zu untersuchen, wurde das Peptid in einem T-Zellrezeptor-Modulationsassay sowie in einem MHC-Kompetitionsassay getestet. Die Ergebnisse zeigten, dass A1.5 nicht die T-Zellproliferation über den T-Zellrezeptor inhibiert, sondern über die verstärkte Bindung an das MHC-Klasse-II Molekül, wodurch das Peptid P1 wahrscheinlich aus der Bindungstasche verdrängt wird. Dieses Ergebnis wurde von weiteren in vivo Daten unterstützt. Wurden beide Peptide getrennt und nicht im Gemisch appliziert, konnte A1.5 die abstoßungsinduzierende Wirkung von P1 nicht mehr kompensieren, und das Transplantat wurde zum gleichen Zeitpunkt nach Transplantation abgestoßen wie in P1-immunisierten Tieren. KW - Allotransplantatabstossung KW - Allopeptidb KW - immundominant KW - MHC-Klass I KW - Peptidanaloge KW - allograft rejection KW - allopeptide KW - immunodominant KW - MHC I KW - peptide analogs Y1 - 2003 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-4561 ER -